{"id":2387,"date":"2019-05-29T00:00:00","date_gmt":"2019-05-29T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2387"},"modified":"2019-05-29T00:00:00","modified_gmt":"2019-05-29T00:00:00","slug":"centogene-lanza-un-estudio-global-de-dos-anos-sobre-la-enfermedad-de-parkinson","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/es\/centogene-launches-two-year-global-parkinsons-disease-study\/","title":{"rendered":"CENTOGENE lanza un estudio global de dos a\u00f1os sobre la enfermedad de Parkinson"},"content":{"rendered":"<p>Cambridge, MA, EE. UU. y Rostock, Alemania, 13 de mayo de 2019: CENTOGENE anunci\u00f3 hoy el inicio de un estudio global de 24 meses para investigar los factores gen\u00e9ticos en la enfermedad de Parkinson, uno de los trastornos neurodegenerativos m\u00e1s comunes que afecta aproximadamente al 1 por ciento de las personas mayores de 60 a\u00f1os. El &quot;Estudio internacional de la enfermedad de Parkinson de Rostock&quot; (ROPAD) se est\u00e1 llevando a cabo en cooperaci\u00f3n con la Universidad de L\u00fcbeck y se espera que sea el estudio m\u00e1s grande y completo de su tipo sobre la enfermedad de Parkinson.<\/p>\n<p>El estudio pretende inscribir a aproximadamente 10.000 participantes en todo el mundo para crear una cohorte con un amplio historial gen\u00e9tico que refleje la poblaci\u00f3n mundial. El objetivo es comprender a fondo cu\u00e1ntas y cu\u00e1les mutaciones gen\u00e9ticas en los genes asociados a la enfermedad de Parkinson (EP) est\u00e1n vinculadas al desarrollo de la enfermedad. CENTOGENE utilizar\u00e1 CentoCard\u00ae, su kit patentado de recolecci\u00f3n de muestras de sangre seca con marcado CE, para identificar a los participantes con una mutaci\u00f3n en LRRK2, GBA y otros genes asociados a la EP.<\/p>\n<p>Los pacientes con mutaciones en los genes de la EP tendr\u00e1n la opci\u00f3n de someterse a una evaluaci\u00f3n cl\u00ednica adicional en un estudio complementario, el \u2018Proyecto Internacional de la Enfermedad de Parkinson LRRK2 (LIPAD)\u2019, realizado en la Universidad de L\u00fcbeck bajo la direcci\u00f3n de la profesora Christine Klein. En este estudio, se realizar\u00e1 un fenotipado detallado de los participantes para describir la frecuencia de todos los signos y s\u00edntomas cl\u00ednicos importantes de la EP. A los pacientes inscritos en ROPAD con una mutaci\u00f3n en LRRK2 tambi\u00e9n se les podr\u00eda ofrecer participar en futuros estudios cl\u00ednicos con Denali Therapeutics, socio del estudio, que desarrolla terapias en investigaci\u00f3n para el tratamiento de enfermedades neurodegenerativas y otras enfermedades humanas.<\/p>\n<p>\u201cCENTOGENE se compromete a brindar esperanza a los pacientes y sus familias acortando la odisea diagn\u00f3stica, y nos enorgullece trabajar en este importante estudio que podr\u00eda tener importantes implicaciones para el diagn\u00f3stico y el tratamiento futuros de la enfermedad de Parkinson\u201d, afirm\u00f3 el Dr. Arndt Rolfs, director ejecutivo y fundador de CENTOGENE. \u201cCon demasiada frecuencia, los estudios cl\u00ednicos no reflejan la diversidad \u00e9tnica del mundo, y este estudio es \u00fanico porque trabajamos con todas las etnias del mundo y contrastamos el efecto de los componentes ambientales y la gen\u00e9tica individual. Nos entusiasma la contribuci\u00f3n que CENTOGENE y nuestros socios est\u00e1n realizando para profundizar en el conocimiento de la gen\u00e9tica de la enfermedad de Parkinson\u201d.\u201d<\/p>\n<p>Para obtener m\u00e1s informaci\u00f3n, por favor <a href=\"https:\/\/www.centogene.com\/es\/clinical-studies\/global-patient-testing-programs-hl\/rostock-international-parkinsons-disease-study.html\/\" target=\"_blank\" title=\"Mira la entrevista en v\u00eddeo\">Mira la entrevista en video<\/a> con el director ejecutivo de CENTOGENE, Prof. Arndt Rolfs, MD.<br \/> &nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Uno de los estudios m\u00e1s grandes y con mayor diversidad \u00e9tnica sobre la enfermedad de Parkinson para descubrir la base gen\u00e9tica de uno de los trastornos neurodegenerativos m\u00e1s comunes.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2387","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE Launches Two Year Global Parkinson\u2019s Disease Study | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/centogene-lanza-un-estudio-global-de-dos-anos-sobre-la-enfermedad-de-parkinson\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE Launches Two Year Global Parkinson\u2019s Disease Study | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"One of the largest, most ethnically diverse studies of Parkinson\u2019s disease to uncover the genetic basis of one of the most common neurodegenerative disorders\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/centogene-lanza-un-estudio-global-de-dos-anos-sobre-la-enfermedad-de-parkinson\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-29T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-launches-two-year-global-parkinsons-disease-study\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-launches-two-year-global-parkinsons-disease-study\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE Launches Two Year Global Parkinson\u2019s Disease Study\",\"datePublished\":\"2019-05-29T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-launches-two-year-global-parkinsons-disease-study\\\/\"},\"wordCount\":402,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-launches-two-year-global-parkinsons-disease-study\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-launches-two-year-global-parkinsons-disease-study\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-launches-two-year-global-parkinsons-disease-study\\\/\",\"name\":\"CENTOGENE Launches Two Year Global Parkinson\u2019s Disease Study | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2019-05-29T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-launches-two-year-global-parkinsons-disease-study\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-launches-two-year-global-parkinsons-disease-study\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-launches-two-year-global-parkinsons-disease-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE Launches Two Year Global Parkinson\u2019s Disease Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/es\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE lanza un estudio global de dos a\u00f1os sobre la enfermedad de Parkinson | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/centogene-lanza-un-estudio-global-de-dos-anos-sobre-la-enfermedad-de-parkinson\/","og_locale":"es_ES","og_type":"article","og_title":"CENTOGENE Launches Two Year Global Parkinson\u2019s Disease Study | CENTOGENE","og_description":"One of the largest, most ethnically diverse studies of Parkinson\u2019s disease to uncover the genetic basis of one of the most common neurodegenerative disorders","og_url":"https:\/\/www.centogene.com\/es\/centogene-lanza-un-estudio-global-de-dos-anos-sobre-la-enfermedad-de-parkinson\/","og_site_name":"CENTOGENE","article_published_time":"2019-05-29T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admincg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-launches-two-year-global-parkinsons-disease-study\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-launches-two-year-global-parkinsons-disease-study\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE Launches Two Year Global Parkinson\u2019s Disease Study","datePublished":"2019-05-29T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-launches-two-year-global-parkinsons-disease-study\/"},"wordCount":402,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-launches-two-year-global-parkinsons-disease-study\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-launches-two-year-global-parkinsons-disease-study\/","url":"https:\/\/www.centogene.com\/centogene-launches-two-year-global-parkinsons-disease-study\/","name":"CENTOGENE lanza un estudio global de dos a\u00f1os sobre la enfermedad de Parkinson | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2019-05-29T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-launches-two-year-global-parkinsons-disease-study\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-launches-two-year-global-parkinsons-disease-study\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-launches-two-year-global-parkinsons-disease-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE Launches Two Year Global Parkinson\u2019s Disease Study"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"administrador","url":"https:\/\/www.centogene.com\/es\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=2387"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2387\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=2387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/categories?post=2387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/tags?post=2387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}